---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-049677"
form_type: "8-K"
ticker: "EMMA"
cik: "0000822370"
company_name: "Emmaus Life Sciences, Inc."
filed_at: "2022-08-19T23:59:59+00:00"
generated_at: "2026-06-23T22:39:46.730066+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Emmaus Life Sciences obtains $1.9M in related-party loans at 10% to prepay debt

## Summary
- CEO Yutaka Niihara and wife loaned $1,576,574 net; includes $250k personal funds.
- Two promissory notes ($1,668,751 and $250,000) due Aug 2027, 10% interest monthly.
- Affiliate Hope International Hospice loaned $50,000 on demand note also at 10%.
- Proceeds used to prepay $1,924,819 of third-party indebtedness.
- Further related-party loans beyond previously reported in 2021/2022 filings.

## SEC filing metadata
- accession: 0001213900-22-049677
- form_type: 8-K
- ticker: EMMA
- cik: 0000822370
- company_name: Emmaus Life Sciences, Inc.
- filed_at: 2022-08-19T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/822370/000121390022049677/0001213900-22-049677-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/822370/000121390022049677/ea164601-8k_emmauslife.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-049677
- JSON: https://secwatch.observer/filing/0001213900-22-049677.json
- Plain text: https://secwatch.observer/filing/0001213900-22-049677.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.